Treating obesity using glucagon-like peptide-1-directed N-methyl-D-aspartate receptor inhibition Post author: Post published:May 20, 2024 Post category:uncategorized Bimodal drug that successfully cures obesity, hyperglycemia, and dyslipidemia in mouse models. You Might Also Like Blood test shows high accuracy in detecting Alzheimer’s disease June 7, 2025 US funding freeze halts malaria prevention and genomic research June 1, 2025 Mineralocorticoid receptor antagonists reduce risk of cardiovascular events in patients with heart failure September 3, 2024
Mineralocorticoid receptor antagonists reduce risk of cardiovascular events in patients with heart failure September 3, 2024